✦ LIBER ✦

5-fluorouracil, epirubicin and cyclophosphamide, as first-line cytotoxic chemotherapy for disseminated breast carcinoma. A phase II study

✍ Scribed by J. Carmo-Pereira; E. Henriques; F. Oliveira Costa

Book ID: 113404450
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 406 KB
Volume: 4
Category: Article
ISSN: 0960-9776
DOI: 10.1016/0960-9776(95)90028-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitoxantrone, folinic acid, 5-fluorourac

Mitoxantrone, folinic acid, 5-fluorouracil and prednisone as first-line chemotherapy for advanced breast carcinoma. A phase II study

✍ Carmo-Pereira, J.; Oliveira Costa, F.; Henriques, E. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 383 KB

Cyclophosphamide, epirubicin, high-dose

Cyclophosphamide, epirubicin, high-dose folinic acid and 5-fluorouracil (super-FEC) as first-line chemotherapy for advanced breast cancer: Preliminary results

✍ Zaniboni, Alberto; Simoncini, Edda; Marpicati, Patrizia; Montini, Elisabetta; Fe 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 553 KB

Phase I trial of adjuvant chemotherapy w

Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer

✍ Stephen E. Jones; Robert G. Mennel; George N. Peters; Mary Alice Westrick; Barry 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 263 KB

Epirubicin is a new anthracycline with a potentially more favorable toxicity profile than the parent compound, doxorubicin. Accordingly, the feasibility and toxicity of 6 courses of adjuvant chemotherapy with cyclophosphamide (C), epirubicin (E), and 5-fluorouracil (F) were assessed in 10 patients w

Interim analysis of a phase II trial of

Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma

✍ Hiroji Iwata; Seigo Nakamura; Masakazu Toi; Eisei Shin; Norikazu Masuda; Shinji 📂 Article 📅 2005 🏛 Springer Japan 🌐 English ⚖ 497 KB

Two years of cyclophosphamide and 5-fluo

Two years of cyclophosphamide and 5-fluorouracil as adjuvant chemotherapy for stage II and III breast carcinoma

✍ Dr. E. Caceres; S. Valdivia; M. Cotrina; M. Lingan; L. Leon; M. Gamboa; L. Oliva 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

The results after 6 years of a prospective clinical trial of adjuvant chemotherapy with a regimen of two drugs--cyclophosphamide and 5-fluorouracil (CF)-- for 2 years in 97 women with stage II or III breast cancer are reported. Eligible patients were free from distant metastases. All patients began

374 Vinorelbine, 5 fluorouracil, leucovo

374 Vinorelbine, 5 fluorouracil, leucovorin and cyclophosphamide as first line chemotherapy in metastatic breast cancer (MBC)

✍ P. Turpin; A. Lluch; M.H. Closon; G. Gruia; A. Llombart; R. Fernandez; P.M. Delg 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 153 KB